Valbiotis (FRA:8JD) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:8JD Valbiotis SA FRA:8JD
65 GF Score
Price €0.75
GF Value €1.40
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Valbiotis Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:8JD
65GF Score
Valbiotis SA FRA:8JD
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Valbiotis (FRA:8JD) Overvalued in 2026?

Based on GuruFocus' analysis, Valbiotis stock appears to be undervalued. The current stock price of €0.75 is trading 46.2% below its estimated GF Value™ of €1.40. GuruFocus considers Valbiotis to be Possible Value Trap.

Key valuation signals for FRA:8JD:

  • Short Ratio:
  • GF Value™: €1.40 vs. price of €0.75 (46.2% below fair value)
  • GF Score™: 65/100 with 6 warning signs

No single metric tells the full story. See the FRA:8JD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Valbiotis Business Description

Other Exchanges ALVAL:France
Address 12F rue Paul VATINE, Perigny, La Rochelle, FRA, 17180
Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.
65GF Score

Get the complete analysis for FRA:8JD

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.75
Price
€1.40
GF Value